HomeAMGN • NASDAQ
Amgen Inc
$284.32
After Hours:
$284.79
(0.17%)+0.47
Closed: Mar 28, 7:19:52 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$286.30
Day range
$284.21 - $288.57
Year range
$211.71 - $329.72
Market cap
152.37B USD
Avg Volume
3.06M
P/E ratio
22.77
Dividend yield
3.17%
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
8.20B19.84%
Operating expense
4.42B52.86%
Net income
767.00M-52.54%
Net profit margin
9.36-60.39%
Earnings per share
4.7115.16%
EBITDA
2.05B-34.23%
Effective tax rate
9.98%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
10.94B17.61%
Total assets
97.15B49.19%
Total liabilities
90.92B47.94%
Total equity
6.23B
Shares outstanding
535.92M
Price to book
24.60
Return on assets
1.78%
Return on capital
2.39%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
767.00M-52.54%
Cash from operations
538.00M-79.69%
Cash from investing
-27.09B-679.99%
Cash from financing
2.75B362.54%
Net change in cash
-23.80B-1,170.53%
Free cash flow
-2.84B-196.44%
About
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total. In 2019, the company's largest selling products were Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases, and Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy. Other marketed products include Evenity, Otezla, Prolia, Repatha, and Lumakras. Wikipedia
Founded
Apr 8, 1980
Website
Employees
26,700
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu